Oppenheimer cuts Braze stock price target on lower software multiples

Braze reported Q4 organic revenue growth of 28% YoY (beating consensus by 3%), LTM revenue of $693M (+23% YoY) and a 68% gross margin, delivering record operating margin and bookings growth. Initial FY2027 guidance exceeded Street expectations but implies some deceleration; management cited AI product momentum and share gains. Despite strong fundamentals, the stock is down ~54% over the past year to $18.02, and several brokers adjusted targets (Oppenheimer $30 from $40; Mizuho $40 from $50; Stifel $35 from $40; Barclays raised to $31; Needham $50; Citizens cut to $35).

Analysis

Braze’s product-led AI push creates a two-way lever: it can expand revenue per customer through usage-based features while simultaneously lifting gross margins by automating services. That structural dynamic favors a higher multiple if the company can demonstrate predictable, monetizable AI consumption within 6–12 months; conversely, any slip in feature adoption will be punished more than a typical SaaS miss because investors have already priced an AI-growth optionality.

Multiple compression across software names has opened an asymmetric opportunity: companies that preserve margin expansion while showing sequential monetization inflection get re-rated faster than peers still growing purely on sales spend. For Braze this means near-term margin resilience is as important as headline ARR growth — investors should watch sales efficiency, churn dynamics at the top 20 customers, and any shift toward usage or revenue-share contracts that increase quarter-to-quarter variability.

Risks skew to guidance execution and sentiment-driven volatility over the next 1–3 quarters; a single under-indexed enterprise renewal or a miss on AI monetization milestones could trigger 20–30% downside in the short run. Tactical trades that buy optioned exposure into confirmed product adoption metrics (or pair against legacy incumbents slower to monetize AI) offer asymmetric payoffs, while a more durable multi-quarter view favors owning the name into a demonstrated uplift in AI-driven revenue mix.

Key Decisions for Investors

• Long BRZE equity sized as a satellite position (3–5% portfolio weight) with a 12-month horizon; set a hard 15% stop and target 60–100% upside if AI monetization proves repeatable — reward-to-risk ~4:1 if thesis executes.
• Buy a 9–12 month BRZE call spread (e.g., 30/50 or nearest liquid strikes) to capture re-rating optionality while limiting premium outlay; exit on either a 50% gain or after next two quarterly reports confirming AI revenue contribution.
• Pair trade: long BRZE / short TWLO or HUBS (equal $ exposure) over 3–9 months to isolate AI-monetization vs. legacy CRM/comm spend dynamics; size smaller (1–2% net) and rebalance on major earnings beats/misses.
• If volatility spikes into earnings, sell a covered call against new-long positions or buy puts to hedge near-term guidance risk (cost should not exceed 2–3% of position value) — protects against a sentiment-driven 20–30% drawdown while keeping upside exposure.